- Home
- CCU vs BLTE Comparison
CCU vs BLTE Comparison
Compare CCU & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- BLTE
- Stock Information
- Founded
- CCU 1850
- BLTE 2018
- Country
- CCU Chile
- BLTE United States
- Employees
- CCU N/A
- BLTE N/A
- Industry
- CCU Beverages (Production/Distribution)
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- CCU Consumer Staples
- BLTE Health Care
- Exchange
- CCU Nasdaq
- BLTE Nasdaq
- Market Cap
- CCU 2.3B
- BLTE 2.1B
- IPO Year
- CCU 1992
- BLTE 2022
- Fundamental
- Price
- CCU $15.63
- BLTE $64.50
- Analyst Decision
- CCU Strong Sell
- BLTE Strong Buy
- Analyst Count
- CCU 2
- BLTE 4
- Target Price
- CCU $9.70
- BLTE $96.67
- AVG Volume (30 Days)
- CCU 253.8K
- BLTE 46.4K
- Earning Date
- CCU 05-07-2025
- BLTE 05-12-2025
- Dividend Yield
- CCU 2.41%
- BLTE N/A
- EPS Growth
- CCU 52.33
- BLTE N/A
- EPS
- CCU 0.44
- BLTE N/A
- Revenue
- CCU $2,922,923,314.00
- BLTE N/A
- Revenue This Year
- CCU $3.80
- BLTE N/A
- Revenue Next Year
- CCU $4.87
- BLTE N/A
- P/E Ratio
- CCU $17.22
- BLTE N/A
- Revenue Growth
- CCU 13.21
- BLTE N/A
- 52 Week Low
- CCU $10.00
- BLTE $31.01
- 52 Week High
- CCU $15.67
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- CCU 65.47
- BLTE 50.01
- Support Level
- CCU $15.05
- BLTE $64.18
- Resistance Level
- CCU $15.43
- BLTE $65.85
- Average True Range (ATR)
- CCU 0.32
- BLTE 2.05
- MACD
- CCU -0.06
- BLTE -0.57
- Stochastic Oscillator
- CCU 96.77
- BLTE 26.35
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.